Scientific News Boston Scientific Resumes Enrolment In Pulsed Field Ablation Trial

Boston Scientific’s FARAFLEX Study: A Potential Game-Changer in Atrial Fibrillation Treatment

Boston Scientific (($BSX)) announced an update on their ongoing clinical study. Study Overview: The study titled ‘Feasibility Study of the ... Read More

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific ... Read More

Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 ... Read More

Boston Scientific expands Farapulse’s reach in afib with new FDA approval

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use into patients with persistent atrial fibrillation lasting at least seven ... Read More

Boston Scientific Reports FDA Approval For Expanded Labeling For FARAPULSE

(RTTNews) - Boston Scientific (BSX) has received FDA approval to expand the instructions for use labeling for the FARAPULSE Pulsed Field Ablation System. The updated labeling now includes approval for ... Read More

FDA approves expanded indication of pulsed field ablation systems for persistent AF

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pulsed field ablation catheter for refractory, ... Read More

Boston Scientific continues to win in electrophysiology

Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players. Read More

Boston Scientific Presses Its Advantage in Pulsed Field Ablation

Boston Scientific has proven itself to be a fierce competitor among three major cardiac device makers, with a track record of meaningful innovation and impressive operational chops. Even a prolonged ... Read More

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) ... Read More